37th Pharmacovigilance UK & EU 2025

The 37th Pharmacovigilance UK & EU 2025 is a premier event dedicated to advancing drug safety and regulatory compliance across the pharmaceutical and biotechnology sectors. Bringing together global experts from organizations like Pfizer, Roche, Bayer, Johnson & Johnson, Gilead Sciences, and Novartis, the conference explores critical topics such as signal detection, AI integration in safety monitoring, and the evolving regulatory landscape. Attendees can gain insights into real-world evidence, adverse event reporting, and global pharmacovigilance strategies to ensure patient safety and drug efficacy. Key highlights include sessions led by industry pioneers like Michael Bean (Johnson & Johnson), Zina Sadeq (Amicus Therapeutics), and Tanuja Halady (Merck KGaA), alongside interactive workshops and case studies. The event fosters collaboration through networking opportunities with senior leaders, regulatory authorities, and safety professionals. Whether you’re aiming to strengthen your pharmacovigilance frameworks or explore the latest innovations in drug safety, this conference provides unparalleled expertise and actionable strategies.